Advanced Enzymes Technologies Ltd. has announced a favorable resolution in its lawsuit against World Nutrition Inc. The decision of the United States Court of Appeals for the Ninth Circuit resulted in the reversal of a ₹159.64 million provision. The reversal was noted by the Audit Committee, and the un-audited results for the quarter and nine months ended December 31, 2025, were approved by the Board of Directors.
Favorable Legal Outcome
Advanced Enzymes Technologies has received a positive outcome regarding the lawsuit filed by World Nutrition Inc. (WNI) against Advanced Supplementary Technologies Corporation, USA (“AST”), a step-down wholly-owned subsidiary.
Reversal of Provision
Based on the decision of the United States Court of Appeals for the Ninth Circuit, the company was able to reverse a provision of ₹159.64 million. This provision had been previously created in respect of the said lawsuit.
Financial Impact
The reversal has been reflected in the financial results for the quarter ended December 31, 2025. The Audit Committee noted this reversal during its meeting. The Board of Directors approved the un-audited financial results for the quarter and nine months ended December 31, 2025, reflecting this positive legal development.
Source: BSE
